Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma

Figure 8

The clinicopathological significance of risk score and MRMs in HCC. (a) Risk score and age. (b) Risk score and pathology grade. (c) Risk score and clinical stage. (d) miR-29c-5p expression level and pathology grade. (e) miR-29c-5p expression level and clinical stage. (f) miR-140-3p expression level and age. (g) miR-140-3p expression level and gender. (h) miR-140-3p expression level and clinical stage. (i) miR-149-5p expression level and clinical stage.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)